- Home
- USNA vs EYPT Comparison
USNA vs EYPT Comparison
Compare USNA & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USNA
- EYPT
- Stock Information
- Founded
- USNA 1992
- EYPT 1987
- Country
- USNA United States
- EYPT United States
- Employees
- USNA N/A
- EYPT N/A
- Industry
- USNA Medicinal Chemicals and Botanical Products
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- USNA Health Care
- EYPT Industrials
- Exchange
- USNA Nasdaq
- EYPT Nasdaq
- Market Cap
- USNA 565.5M
- EYPT 741.0M
- IPO Year
- USNA 1996
- EYPT 2005
- Fundamental
- Price
- USNA $20.51
- EYPT $13.20
- Analyst Decision
- USNA Hold
- EYPT Strong Buy
- Analyst Count
- USNA 1
- EYPT 6
- Target Price
- USNA $36.00
- EYPT $25.83
- AVG Volume (30 Days)
- USNA 174.1K
- EYPT 1.1M
- Earning Date
- USNA 10-21-2025
- EYPT 11-06-2025
- Dividend Yield
- USNA N/A
- EYPT N/A
- EPS Growth
- USNA N/A
- EYPT N/A
- EPS
- USNA 1.80
- EYPT N/A
- Revenue
- USNA $899,221,000.00
- EYPT $51,898,000.00
- Revenue This Year
- USNA $13.94
- EYPT N/A
- Revenue Next Year
- USNA $7.95
- EYPT N/A
- P/E Ratio
- USNA $11.46
- EYPT N/A
- Revenue Growth
- USNA 2.75
- EYPT 2.99
- 52 Week Low
- USNA $19.92
- EYPT $3.91
- 52 Week High
- USNA $41.84
- EYPT $14.91
- Technical
- Relative Strength Index (RSI)
- USNA 15.87
- EYPT 50.66
- Support Level
- USNA $19.88
- EYPT $13.00
- Resistance Level
- USNA $27.95
- EYPT $14.36
- Average True Range (ATR)
- USNA 0.92
- EYPT 0.91
- MACD
- USNA -0.78
- EYPT -0.14
- Stochastic Oscillator
- USNA 7.31
- EYPT 27.85
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.